OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability
Ria Schönauer, Sylvia Els‐Heindl, Jan‐Patrick Fischer, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 12, pp. 5695-5705
Closed Access | Times Cited: 23

Showing 23 citing articles:

Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau, Michael K. Dunn
Bioorganic & Medicinal Chemistry (2017) Vol. 26, Iss. 10, pp. 2700-2707
Open Access | Times Cited: 1610

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Debbie L. Hay, Michael L. Garelja, David R. Poyner, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 1, pp. 3-17
Open Access | Times Cited: 334

Peptide hormones and lipopeptides: from self‐assembly to therapeutic applications
Jessica Hutchinson, Samuel Burholt, Ian W. Hamley
Journal of Peptide Science (2017) Vol. 23, Iss. 2, pp. 82-94
Open Access | Times Cited: 89

Adrenomedullin – new perspectives of a potent peptide hormone
Ria Schönauer, Sylvia Els‐Heindl, Annette G. Beck‐Sickinger
Journal of Peptide Science (2017) Vol. 23, Iss. 7-8, pp. 472-485
Closed Access | Times Cited: 71

Adrenomedullin: Continuing to explore cardioprotection
Toshihiro Tsuruda, Johji Kato, Kenji Kuwasako, et al.
Peptides (2018) Vol. 111, pp. 47-54
Closed Access | Times Cited: 45

Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential
Jan‐Patrick Fischer, Sylvia Els‐Heindl, Annette G. Beck‐Sickinger
Peptides (2020) Vol. 131, pp. 170347-170347
Closed Access | Times Cited: 35

Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials
Paolo Grieco, Isabel Gómez‐Monterrey
Archives of Biochemistry and Biophysics (2018) Vol. 662, pp. 15-32
Open Access | Times Cited: 33

Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors
Michael L. Garelja, Maggie Au, Margaret A. Brimble, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 2, pp. 246-262
Open Access | Times Cited: 32

Peptide Therapeutics: Current Status and Future Opportunity with Focus on Nose-to-Brain Delivery
Eva‐Maria Jülke, Annette G. Beck‐Sickinger
Peptides (2025), pp. 171404-171404
Closed Access

Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction
Svenja Hinrichs, Katharina Scherschel, Saskia Krüger, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 37
Open Access | Times Cited: 30

Identification and stabilization of a highly selective gastrin‐releasing peptide receptor agonist
Paul Hoppenz, Sylvia Els‐Heindl, Annette G. Beck‐Sickinger
Journal of Peptide Science (2019) Vol. 25, Iss. 12
Open Access | Times Cited: 20

The processing intermediate of human amylin, pro-amylin(1–48), has in vivo and in vitro bioactivity
Giulia Mazzini, Christelle Le Foll, Christina N. Boyle, et al.
Biophysical Chemistry (2024) Vol. 308, pp. 107201-107201
Open Access | Times Cited: 2

Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice
Esben M. Bech, Kristoffer Voldum-Clausen, Søren L. Pedersen, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 167-173
Open Access | Times Cited: 18

Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Related Peptide Receptors
Jason M. Booe, Margaret L. Warner, Augen A. Pioszak
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 4, pp. 759-772
Open Access | Times Cited: 16

Rational design of highly stabilized and selective adrenomedullin analogs
Eva‐Maria Jülke, Jan‐Patrick Fischer, Sylvia Els‐Heindl, et al.
Journal of Peptide Science (2023) Vol. 29, Iss. 12
Open Access | Times Cited: 4

Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation
Jan‐Patrick Fischer, Ria Schönauer, Sylvia Els‐Heindl, et al.
Journal of Peptide Science (2019) Vol. 25, Iss. 3
Closed Access | Times Cited: 10

The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor‐like Receptor/Receptor Activity‐Modifying Protein System
Jan‐Patrick Fischer, Sylvia Els‐Heindl, Ria Schönauer, et al.
ChemMedChem (2018) Vol. 13, Iss. 17, pp. 1797-1805
Open Access | Times Cited: 7

Thrombin rapidly digests adrenomedullin: Synthesis of adrenomedullin analogs resistant to thrombin
Yayoi Nishimoto, Sayaka Nagata, Emiko Akashi, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 529, Iss. 3, pp. 778-783
Closed Access | Times Cited: 3

Picomolar affinity antagonist and sustained signaling agonist peptide ligands for the adrenomedullin and calcitonin gene-related peptide receptors
Jason M. Booe, Margaret L. Warner, Augen A. Pioszak
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1

Peptides, lipopeptides, and severe acute respiratory syndrome coronavirus-2
Furqan Shafqat, Shafeeq Ur Rehman, Muhammad Shan, et al.
Elsevier eBooks (2022), pp. 381-422
Closed Access | Times Cited: 1

<strong>Current Advances in Therapeutic Peptides: Past and Future Trends</strong><strong> </strong>
Ramachandran Chelliah, Eric Banan‐Mwine Daliri, Fazle Elahi, et al.
(2021)
Open Access | Times Cited: 1

Stable adrenomedullin analog mitigates placental ischemia-induced hypertension and fetal growth restriction in rats
Chia Lin Chang, Zheqing Cai, Sheau Yu Hsu
Journal of Hypertension (2023) Vol. 41, Iss. 7, pp. 1127-1141
Closed Access

Trendbericht Biochemie Teil 1: Peptidtherapeutika
Sylvia Els‐Heindl, Kathrin Bellmann‐Sickert
Nachrichten aus der Chemie (2019) Vol. 67, Iss. 7-8, pp. 48-52
Open Access

Page 1

Scroll to top